Pradžia › Hipofaringo vėžys
Hipofaringo vėžys klinikiniai tyrimai JAV ieško dalyvių
19 tyrimai dėl Hipofaringo vėžys ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Atlanta, GA6 tyrimai
- Chicago, IL6 tyrimai
- Stevens Point, WI5 tyrimai
- Joliet, IL5 tyrimai
- Peoria, IL5 tyrimai
- Bloomington, IL5 tyrimai
- Wausau, WI5 tyrimai
- Richmond, VA5 tyrimai
- Cape Girardeau, MO5 tyrimai
- Milwaukee, WI5 tyrimai
- Kansas City, MO5 tyrimai
- New York City, NY4 tyrimai
- Edison, NJ4 tyrimai
- Queens, NY4 tyrimai
- Waukegan, IL4 tyrimai
- Green Bay, WI4 tyrimai
- Cedar Rapids, IA4 tyrimai
- Evanston, IL4 tyrimai
- Danville, IL4 tyrimai
- Fargo, ND4 tyrimai
- Lansing, MI4 tyrimai
- Omaha, NE4 tyrimai
- Champaign, IL4 tyrimai
- Decatur, IL4 tyrimai
- Aurora, IL4 tyrimai
- St. Louis, MO4 tyrimai
- Galesburg, IL4 tyrimai
- Naperville, IL4 tyrimai
- Flint, MI4 tyrimai
- Oklahoma City, OK4 tyrimai
- Charleston, IL4 tyrimai
- Cicero, IL4 tyrimai
- North Peoria, IL4 tyrimai
- Waterford, MI4 tyrimai
- Bozeman, MT4 tyrimai
- Duluth, MN4 tyrimai
- Pittsburgh, PA4 tyrimai
- Baltimore, MD4 tyrimai
- Cincinnati, OH4 tyrimai
- Louisville, KY4 tyrimai
Pagal valstiją
- Aidahas3 tyrimai
- Ajova6 tyrimai
- Arizona3 tyrimai
- Arkansas4 tyrimai
- Džordžija6 tyrimai
- Florida8 tyrimai
- Ilinoisas7 tyrimai
- Indianas4 tyrimai
- Kalifornija7 tyrimai
- Kanzasas6 tyrimai
- Kentukis4 tyrimai
- Koloradas6 tyrimai
- Masčusetsas5 tyrimai
- Merilendas5 tyrimai
- Minesota6 tyrimai
- Misūris6 tyrimai
- Mičiganas5 tyrimai
- Montana4 tyrimai
- Nebraska4 tyrimai
- New Jersey4 tyrimai
- New York8 tyrimai
- North Carolina5 tyrimai
- North Dakota4 tyrimai
- Ohio8 tyrimai
- Oklahoma4 tyrimai
- Oregon3 tyrimai
- Pennsylvania6 tyrimai
- South Dakota3 tyrimai
- Texas3 tyrimai
- Virginia5 tyrimai
- Wisconsin6 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06997068BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT07441681Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-29 · NCT04198766Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-16 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-15 · NCT01365169Integrated Cancer Repository for Cancer Research
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-15 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-04 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-19 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-11 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-10 · NCT01473784Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-22 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 21 iki 90 · Visoms lytims · Atnaujinta 2025-09-22 · NCT00900419Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.